DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Chronic Obstructive Pulmonary Disease (COPD) Patients Diagnosed With Gastro Esophageal Reflux Disease (GERD). Rates of COPD Exacerbations After Treatment With High Dose Proton Pump Inhibitor Therapy

Information source: University of Florida
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Gastroesophageal Reflux; Chronic Obstructive Pulmonary Disease

Phase: N/A

Status: Recruiting

Sponsored by: University of Florida

Official(s) and/or principal investigator(s):
Kenneth Vega, MD, Principal Investigator, Affiliation: University of Florida - Jacksonville

Overall contact:
Kenneth Vega, MD, Phone: 904-633-0089, Email: kenneth.vega@jax.ufl.edu

Summary

The purpose of this study is to determine which COPD patients have GERD and if COPD patients with GERD treated with high dose lansoprazole for 1 year decreases the frequency of COPD exacerbations compared to the previous year without treatment.

Clinical Details

Official title: COPD Patients Diagnosed With Gastro Esophageal Reflux Disease Have Decreased Rates of COPD Exacerbations After Treatment With High Dose Proton Pump Inhibitor Therapy (Esomeprazole or Lansoprazole)

Study design: Other, Prospective

Eligibility

Minimum age: 40 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- diagnosis of COPD

- forced expiratory volume/forced vital capacity ratio (FEV1/FVC) of < 70% on

pulmonary function testing

- age > 40 years

- >20 pack year history of smoking

Exclusion Criteria:

- presence of the following disorders: respiratory disorders other than COPD, known

esophageal disease such as cancer, achalasia, stricture, active peptic ulcer disease, Zollinger-Ellison syndrome, mastocytosis, scleroderma, or current abuse of alcohol defined as greater than three alcoholic drinks per day.

Locations and Contacts

Kenneth Vega, MD, Phone: 904-633-0089, Email: kenneth.vega@jax.ufl.edu

University of Florida, Jacksonville, Florida 32207, United States; Recruiting
Kenneth Vega, MD, Phone: 904-633-0089, Email: kenneth.vega@jax.ufl.edu
Lakina Campbell, MS, CCRP, Phone: 904-633-0089, Email: lakina.campbell@jax.ufl.edu
Kenneth Vega, MD, Principal Investigator
Additional Information

Starting date: August 2007
Last updated: June 23, 2008

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009